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Abstract
The Gram-positive bacterium Propionibacterium acnes is a member of the normal human skin microbiota and is associated
with various infections and clinical conditions. There is tentative evidence to suggest that certain lineages may be
associated with disease and others with health. We recently described a multilocus sequence typing scheme (MLST) for P.
acnes based on seven housekeeping genes (http://pubmlst.org/pacnes). We now describe an expanded eight gene version
based on six housekeeping genes and two ‘putative virulence’ genes (eMLST) that provides improved high resolution
typing (91eSTs from 285 isolates), and generates phylogenies congruent with those based on whole genome analysis. When
compared with the nine gene MLST scheme developed at the University of Bath, UK, and utilised by researchers at Aarhus
University, Denmark, the eMLST method offers greater resolution. Using the scheme, we examined 208 isolates from
disparate clinical sources, and 77 isolates from healthy skin. Acne was predominately associated with type IA1 clonal
complexes CC1, CC3 and CC4; with eST1 and eST3 lineages being highly represented. In contrast, type IA2 strains were
recovered at a rate similar to type IB and II organisms. Ophthalmic infections were predominately associated with type IA1
and IA2 strains, while type IB and II were more frequently recovered from soft tissue and retrieved medical devices. Strains
with rRNA mutations conferring resistance to antibiotics used in acne treatment were dominated by eST3, with some
evidence for intercontinental spread. In contrast, despite its high association with acne, only a small number of resistant CC1
eSTs were identified. A number of eSTs were only recovered from healthy skin, particularly eSTs representing CC72 (type II)
and CC77 (type III). Collectively our data lends support to the view that pathogenic versus truly commensal lineages of P.
acnes may exist. This is likely to have important therapeutic and diagnostic implications.
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Introduction
Propionibacterium acnes is a Gram-positive aerotolerant anaerobe
that forms part of the normal resident microbiota of the skin, oral
cavity and the gastrointestinal and genito-urinary tracts [1]. It is an
opportunistic pathogen and has been linked to a wide range of
infections and conditions, including acne vulgaris [2], medical
device [3–5], dental [6] and ophthalmic [7] infections, as well as
synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome
[8], sarcoidosis [9,10] and prostate cancer [11]. Previously, we
demonstrated that P. acnes comprises four highly distinct evolu-
tionary lineages, known as type IA, IB, II and III that display
differences in inflammatory properties, production of virulence
determinants and association with various conditions [12–16].
To build and expand on these earlier phylogenetic and
epidemiological studies, we recently described a multilocus
sequence typing (MLST) scheme for P. acnes which was validated
against Random Amplification of Polymorphic DNA (RAPD) and
antibody typing methods [17]. This scheme and its corresponding
database, which were established in 2005 and announced on
http://pubmlst.org/, is based on partial nucleotide sequences
from seven core housekeeping genes (3135 bp). Upon concatenat-
ed gene sequence analysis, this original MLST resolves isolates
into specific sequence types (STs) within the phylogenetic divisions
IA, IB, II and III, and also divides strains from the large type IA
clade into two highly distinct groups, designated types IA1 and IA2,
which is supported by phylogenomic analysis of multi-housekeep-
ing gene datasets compiled from completed and currently ongoing
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P. acnes whole genome sequencing projects [17–19]. We previously
used this MLST scheme to highlight the association of acne and
ophthalmic infections with STs from the type IA division [17] and
since then, the method has also been utilised by other research
groups [20]. A recent study by Kilian et al. [18] demonstrated that
MLST analysis with nine housekeeping genes affords additional
discriminatory power for the identification of particular P. acnes
clones and lineages (hereafter called the Aarhus scheme) when
compared to our previously described method based on fewer loci.
Their protocol utilises the genes and their corresponding primer
sequences that were originally developed for the typing of P. acnes
at the University of Bath, UK (O’Hanlon et al.; http://www.mlst.
net/comingsoon/pacnes.asp), only one of which (recA) is shared
between the two schemes. The increased window of discrimination
described with the use of additional genes primarily relates to the
type IA1 clade and, in particular, isolates previously classified as
genotype ST6 [17]; although the clinical relevance of these
additional subtypes has not been clearly established. Against this
background, we now report an updated and expanded MLST
(eMLST) method in which one housekeeping gene (recA) has been
removed, and the complete sequences from two ‘putative
virulence’ genes, namely a haemolysin (tly) and a Christie-Atkins-
Munch-Petersen (CAMP) factor homologue (camp 2) added. This
eight-gene based version (4253 bp) demonstrates greater levels of
resolution compared to the MLST method originally described by
Lomholt and Kilian [21] when analysed against a panel of 86 P.
acnes isolates. We describe application of the expanded scheme to a
large collection of isolates recovered from diverse clinical samples
(n = 208), as well as healthy skin (n = 77), to investigate whether
‘pathogenic’ versus truly ‘commensal’ lineages may exist. We also
describe the first population genetic analysis of isolates with rRNA
mutations conferring resistance to tetracyclines, erythromycin and
clindamycin, antibiotics commonly used to treat acne patients.
Results and Discussion
Allelic Variation in Virulence and Surface Antigen Genes
To further develop our MLST scheme for enhanced discrim-
ination of isolates, primarily those from the type I clade, we
examined a range of genes that encode ‘putative virulence’ factors.
Such genes, especially those encoding cell surface-associated
antigens, are being increasing utilised in MLST schemes as they
may be under positive selection, which can result in enhanced
diversity and discriminatory power, and can also provide
information on the evolution of virulence [22,23].
We identified a number of candidate genes (n = 11) from the
literature that encode ‘putative virulence’ factors and cell surface
antigens in P. acnes and assessed their suitability for our eMLST
scheme based on their locations within the genome and levels of
diversity (Table 1). Genes selected included two putative cell
invasion-associated proteins (pamce; pap60) [24], a secreted
triacylglycerol lipase (gehA) [25,26] and two highly immunoreactive
cell surface antigens (htaA; hsp20). The latter includes a protein
similar to the product of the Corynebacterium diptheriae htaA gene that
encodes an iron regulated hemin-binding protein [15] and a heat
shock protein (hsp20) that encodes an alpha-crystallin-like protein
which is homologous to the immunodominant antigen HspX of
Mycobacterium tuberculosis [26]. For comparison, we also included a
putative haemolysin/cytotoxin (tly) gene and a family of five co-
haemolytic Christie-Atkins-Munch-Peterson (camp) factor homo-
logue genes [12,14] Previous population genetic studies of P. acnes
demonstrated that phylogenetic trees based on tly and CAMP
factor gene sequences correctly cluster isolates into the main
genetic divisions (I, II and III), suggesting they have co-evolved
with housekeeping genes [12,14]. To date, the precise biological
function of CAMP factors and their role in bacterial virulence is
unclear, although an ability to function as immunoglobulin-
binding proteins or pore-forming toxins have been suggested [27].
In the case of P. acnes, the five CAMP factor homologues are likely
to have arisen by multiple gene duplication events resulting in
paralogous sequences that now encode proteins with unknown and
divergent functions (Figure S1). Previously described genes
encoding immunogenic dermatan-sulfate binding adhesins
(DsA1; DsA2) with putative phase/antigenic variation signatures
were not included in the analysis due to the potential for within
clone variation in sequences encoding PT repeat regions [15,17].
The number of distinct alleles, polymorphic sites and ratio of
non-synonymous-to-synonymous mutations (dNdS) were initially
investigated for each candidate gene using data currently available
from the Human Microbiome Project (HMP) [Huiying Li (2010);
http://precedings.nature.com/documents/5305/version/1] as
well as completed genome sequencing projects for the isolates
KPA171202 (type IB) [28], 6609 (type IB) [29] and ATCC11828
(type II) [30]. HMP isolates represented by HL037PA2,
HL037PA3 and HL044PA1 were not included in our analyses
as these organisms have recently been proposed as a new species,
Propionibacterium humerusii [31]. We also observed that the isolate
SK182B-JCVI shared only 91% identity to P. acnes based on recA,
whereas the main genetic divisions within P. acnes (I, II and III) are
98–99% identical based on this locus, suggesting that it may also
represent a novel species despite the high 16 S rRNA sequence
identity (99%). On this basis, it was also excluded.
With this cohort of isolates, the number of individual alleles for
the genes varied from six (hsp20) to 16 (pap60), with the number of
polymorphic sites ranging from 12 (2.61%; hsp20) to 52 (4.49%;
pap60). Overall, the level of diversity was low as reflected in the h
and p values calculated for each gene. The proportion of
polymorphic sites was similar to that previously found with core
housekeeping genes [17]. With the exception of the gehA gene, all
candidate loci had dNdS ,1 indicating stabilising selection,
although with camp2 and pap60 genes a slight increase in the
number of non-synonymous versus synonymous changes was
observed. Collectively, the results obtained are consistent with
previous studies of tly and CAMP factor gene sequences which had
polymorphic changes consistent with a lack of selection for
enhanced diversification [12,14,21]. While the dNdS ratio.1
observed with gehA is suggestive of a possible role for diversifying
or positive selection in the history of this gene, the Tamija’s D
value for gehA and all other loci did not deviate significantly from
zero (p.0.10) which was consistent with neutral (random)
evolution (Table 1). Tajima’s D test is based on the differences
between the number of segregating sites (h) and the pairwise
nucleotide diversity (p). Furthermore, analysis of individual codons
for positive selection using the single likelihood ancestor counting
(SLAC) method with the General Reversible (REV) and HKY85
models of nucleotide substitution did not provide any evidence for
positively selected sites within the lipase gene.
Selection of Virulence Genes for eMLST
From our initial analyses, four loci were selected and
investigated for their suitability in an eMLST scheme; these were
genes encoding tly, CAMP factor homologue 2 (camp2), gehA and
pap60. Complete rather than partial gene sequences were
examined to maximise discriminatory power. For comparative
purposes, all 71 isolates from the HMP and other whole genome
sequencing projects were initially analysed using our previously
described MLST scheme which is based on partial sequences from
seven core housekeeping genes [17]. A total of 21 STs were
Expanded MLST for Propionibacterium acnes
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identified using the originally described method and included 14
STs from the type I division (RAPD group 01) (type IA & IB),
which split into nine STs representing the type IA1 cluster, three
STs representing type IA2, one ST representing the type IB
grouping, and a novel ST placed within the broader type I clade
pending further analysis. A total of seven STs were from the type
II division (RAPD group 02). Interestingly, no type III isolates
(RAPD group 03) were found in the HMP P. acnes collection. Type
IA1 STs were represented by ST1 (n = 1), ST6 (n = 32), ST11
(n = 1), ST25 (n = 1), ST39 (n = 1), ST49 (n = 2), ST50 (n = 1),
ST57 (n = 1) and ST58 (n = 1); type IA2 STs by ST9 (n = 15),
ST22 (n = 1), ST45 (n = 1); all type IB isolates by ST10 (n = 3) and
the novel genotype by ST29 (n = 1). Type II STs were represented
by ST35 (n = 2), ST40 (n = 1), ST42 (n = 2), ST44 (n = 1), ST46
(n = 1), ST47 (n = 1) and ST48 (n = 1).
All of the P. acnes isolates were then analysed by eMLST with
the addition of the complete gene sequences from tly (777 bp),
camp2 (858 bp) and gehA (1020 bp), to give an initial 10 locus-based
scheme (5736 bp). The pap60 gene was not included in this
preliminary analysis due to its adjacent genomic location to the
camp2 locus. In total, 30 eMLST STs (eSTs) were resolved. Isolates
represented by ST6 were sub-divided into nine distinct STs. The
replacement of camp2 with pap60 did not provide any significant
improvement in subtyping and consequently, the camp2 locus was
retained due to its smaller size and therefore suitability for
nucleotide sequence analysis (data not shown). When all the
isolates were then analysed with only the tly and camp2 genes
present (lipase gene removed) the same number of eSTs (n = 30)
were obtained. Furthermore, although the recA gene has proved a
robust and valuable locus for broad discrimination of the major
clades or phylogroups (I, II and III), its removal did not result in
any reduction in the number of STs resolved, or change the
clustering observed upon eBURST analysis (data not shown). On
this basis, an MLST methodology based on aroE, atpD, gmk, guaA,
lepA, sodA, tly and camp2 sequences was adopted. The P. acnes
MLST database has now been updated to include all novel allele
sequences for tly and camp2 putative virulence determinants, along
with new allelic profiles and ST designations based on the eight-
locus scheme (http://pubmlst.org/pacnes).
Comparison of Original MLST and eMLST Schemes for
Resolution of STs
To date, the original P. acnes MLST database comprises 62 STs
from the analysis of 314 isolates, including all HMP isolates. These
isolates have been recovered from acne, medical device, ophthal-
mic, dental and soft tissue infections, and healthy skin, and cover
all four continents. For a more comprehensive comparison of our
original and expanded MLST schemes, a total of 285 isolates
(including all HMP and other whole genome sequence strains)
from our current isolate database were analysed (Table S1). These
isolates were selected to represent all 62 STs recovered from a
wide range of sources and geographical regions, and included 145
isolates from the type IA1 division, 32 isolates from type IA2, four
novel type I isolates, 40 type IB isolates, 38 type II isolates and 26
type III isolates.
With the eMLST method, a total of 91 eSTs were identified
demonstrating additional resolution (Table S1). A total of 42 eSTs
were resolved from the type IA1 division, seven eSTs from type
IA2, nine eSTs from type IB, two eSTs from the novel type I
group, 22 eSTs from type II and nine eSTs from type III. In
particular, isolates represented by ST6 (n = 105) were subtyped
into a further 14 additional eSTs, with eST1 representing the most
predominant genotype (n = 50; 48%) followed by eST3 (n = 26;
25%), eST4 (n = 15; 14%) and eST8 (n = 4; 4%). The remaining
10 eSTs only represented one isolate each. In the development of
our previous method we found little additional resolution when we
examined a subset of ST6 strains with nine partial gene sequences
versus seven; and in this study we found that a large proportion of
the ST6 isolates we previously described retained the same ST
(eST1) upon eMLST analysis [17].
With the widespread type IB genotype ST10 identified using
our original scheme we found much less variation. Of 36 ST10
isolates examined, 32 retained the same ST with the expanded
scheme (eST5). Similarly, with 22 ST9 isolates from the type IA2
cluster, 20 retained the same ST (eST2). As the type IB and IA2
divisions represent tight monophyletic clusters, there is signifi-
cantly less opportunity for enhanced discrimination and this is
supported by phylogenomic analysis of multi-housekeeping gene
datasets compiled from completed and currently ongoing P. acnes
whole genome sequencing projects [18]. With respect to the large
Table 1. Characteristics of P. acnes ‘putative virulence’ genes based on data from whole genome sequencing projects.
Gene
Size (bp)
analysed Genomic locationa
No. of
alleles
No. polymorphic
sites
% polymorphic
sites N/Sb G+Cmol dNdS h p
Tajima’s
D testc
camp 1 858 1462006–1462863 9 42 4.89 20/22 58.83 0.310 0.018 0.018 0.052
camp 2 804 756689–757492 13 37 4.60 20/17 59.40 0.263 0.015 0.017 0.810
camp 3 816 2282705–2283520 8 16 1.96 6/10 63.83 0.221 0.008 0.006 20.975
camp 4 802 1339073–1339876 10 28 3.48 9/19 58.10 0.091 0.012 0.014 0.576
camp5 846 1305348–1306193 11 27 3.19 11/16 58.15 0.178 0.011 0.011 0.264
Tly 777 1514498–1515273 11 32 4.12 16/16 58.31 0.346 0.014 0.012 20.517
gehA 1020 2278518–2279537 9 14 1.37 10/5 63.46 1.180 0.005 0.005 20.599
pap60 1158 793035–794192 16 52 4.49 26/24 60.30 0.219 0.014 0.016 0.692
pAmce 933 1057639–1058571 13 41 4.39 13/28 62.29 0.142 0.014 0.013 20.460
htaA 1404 865732–866931 12 34 2.42 15/19 57.86 0.245 0.008 0.008 20.074
hsp20 458 808957–809415 6 12 2.61 3/9 61.75 0.087 0.011 0.013 1.016
aRelates to genome sequence of KPA171202 [28].
bRatio of non-synonymous-to-synonymous mutations (v).
cp.0.10 for all Tajima’s D test results.
doi:10.1371/journal.pone.0041480.t001
Expanded MLST for Propionibacterium acnes
PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e41480
type I clade, a total of 60 eSTs were identified versus 38 STs using
the original seven locus scheme [17].
eBURST Clustering of STs
We also compared the original and expanded schemes with
respect to the clustering of isolates using the eBURST algorithm.
The 62 STs identified using our original scheme clustered into a
total of seven eBURST groups or clonal complexes (CCs), along
with two singletons, under the strict definition of sharing 6/7
alleles with at least one other ST (data not shown). With the
expanded eight locus scheme, 91 eSTs clustered into a total of
eight CCs and 21 singletons based on sharing 7/8 alleles with at
least one other ST (Figure 1). All isolates that would be classified as
ST6 based on the original seven locus scheme were split into a
further three CCs (CC1, CC3, CC4) by eMLST. All 15 STs
previously described within the large and dominant type IA clonal
complex CC6 [17] either split into these three CCs or were
singletons (n = 3).
Isolates that cluster within the type IA2 division formed their
own CC (CC2) along with three singletons (ST22; ST23)
confirming their distinct nature. In our previous MLST study,
STs that cluster within this group were provisionally placed in the
IB division (IB2) pending more detailed analysis [17]. This
classification was based on collective criteria including, a type IB
biotype, eBURST clustering with known type IB strains, and the
presence of various housekeeping and virulence gene alleles
matching those found in all type IB isolates; some of the latter loci
being used to identify strains from the type IB division by single
locus phylotyping [6,12,32–34]. Furthermore, in our previous
study of 54 acne isolates, no type IA2 strains were identified, unlike
other type IA STs, suggesting differences in infection profile [17].
Recent whole genome sequencing of three type IA2 isolates (eST2,
eST22 and eST36) has confirmed their classification within the
type IA division, but highlighted consistent genetic differences
from other type IA strains leading to their proposal as type IA2,
with all other type IA isolates as IA1 [19]. Their classification as a
highly distinct division within type IA is also supported by
phylogenomic analysis of multi-housekeeping gene datasets
compiled from completed and currently ongoing P. acnes whole
genome sequencing projects [18]. Strains from the type IB division
have also been shown to contain 86 genes not present in type IA2
organisms, including those involved in carbohydrate metabolism
and genes encoding a bacteriophage [18]. The observation of type
IB housekeeping and ‘putative virulence’ gene sequences in the
type IA2 group, which span a distance of at least ,420 Kbp,
therefore suggests conjugal transfer of very large genomic
fragments in the history of this cluster [17,21].
Selective Pressure
To date, a total of 23 novel tly and 33 novel camp2 alleles have
been identified from 285 isolates, with the camp2 gene currently
representing the greatest number of alleles within our MLST
database. We also identified a novel camp2 allele (allele 33) with an
additional three bp insertion (GGG), likely reflecting slipped
Figure 1. eBURST population snapshot of the eMLST database. A total of eight clonal complexes, where isolates share 7/8 loci with at least
one other eST in the group, and 21 singletons were identified. The frequency of each eST is indicated by the area of each circle. Type IA1 isolates are
represented by CC1, CC3, CC4 and 11 singletons; type IA2 by CC2 and two singletons, type IB by CC5 and one singleton; type II by CC6, CC69 and six
singletons; type III by CC77 and one singleton. Founding genotypes are highlighted in blue and sub-founders in yellow. eSTs only isolated from
healthy skin are circled in green. Note, the spacing between singletons and clonal complexes is not related to the genetic distance between them.
Culture collection strain NCTC737 (type IA1) is represented by eST1 (ST18, Arahus), KPA171202 by eST5 (ST36, Arahus), CCUG32901 by eST5 (ST36,
Arahus) and ATCC11828 by eST27 (novel ST, Arahus).
doi:10.1371/journal.pone.0041480.g001
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strand mispairing, which did not affect the reading frame of the
gene. With our additional sequence data, the number of
percentage polymorphic sites for the tly and camp genes increased
to 6.3% and 9.7%, respectively. The updated dNdS ratio for both
genes was still consistent with purifying selection (tly; 0.299) (camp2;
0.295) and Tajima’s D values with neutral (random) evolution (tly;
20.337, p.0.01) (camp2; 0.150, p.0.01).
To corroborate these results and explicitly demonstrate that the
tly and camp2 genes are not under positive or diversifying selection,
we conducted a number of further analyses. We firstly examined
our data using the tests of selection described by Fu and Li (Ref)
(D* and F*) which examines the hypothesis that all mutations are
selectively neutral and uses the number of singletons (mutations
appearing only once) to infer changes at the tips of a phylogeny
relative to the total number of changes. The D* test statistic is
based on the differences between the number of singletons and the
total number of mutations. The F* test statistic is based on the
differences between the number of singletons and the average
number of nucleotide differences between pairs of sequences. The
D* and F* statistics for the tly (20.311, 20.374, respectively) and
camp2 (20.114, 20.030, respectively) genes were not significant
(p.0.1), again consistent with neutral evolution. SLAC analysis of
the data with REV and HKY85 models of substitution also
provided no evidence for positive selection of any amino acid
(codon) in either protein. We then analysed our data using both
Mixed Effects Model of Episodic Selection (MEME) and
PARtitioning for Robust Inference of Selection (PARRIS)
methods. The MEME program is capable of identifying both
episodic and pervasive positive selection at individual sites and
models dNdS across lineages at an individual site using a two-bin
random distribution. PARRIS robustly identifies overall signatures
of selection by using a partitioning approach and site-to-site
variation in synonomous and non-synonymous rates after
accounting for recombination using the GARD algorithm. With
both approaches, no evidence of episodic diversifying selection was
found in either gene (p.0.1) using both REV and HKY85 models
of substitution, thus confirming the previous tests.
It is clear these genes are not under diversifying selection and
have co-evolved with housekeeping genes. Their presence in all P.
acnes isolates provides evidence of their importance for commensal
existence, and a selective advantage in the ‘non-pathogenic’, as
well as ‘pathogenic’ life of the bacterium preventing their loss from
the population. On this basis, we could consider these genes as
part of the core genome of P. acnes. Various functions have been
ascribed to type III haemolysins, and they are also associated with
other non-pathogenic propionibacteria such as Propionibacterium
freudenreichii subsp. shermanii [1].
Recombination
Evidence for recombination was initially sought by construction
of ME trees for both loci which should be congruent in a clonal
population. The trees generated were essentially concordant with
those previously obtained using housekeeping loci with the major
divisions (I, II and III) forming distinct and highly significant
clades (Figure S2). Some evidence for limited recombination
within the type I division was identified; in particular tly allele 8
which was present in all type IB and 97% type IA2 isolates was also
shared with 18% of type IA1 isolates. The camp2 alleles 1 and 6
were shared between different isolates of type IA1 and IB. Split
decomposition analysis provided further evidence for recombina-
tion events due to the presence of interconnected pathways or
parallelogram structures, but this was very limited and not
statistically significant (phi test; p.0.5) (Figure S3). Furthermore,
GARD analysis and Sawyer’s run test found no evidence of
significant levels of recombination, similar to previous observations
with P. acnes housekeeping genes [17,21].
Previously, we found that the P. acnes population as a whole was
clonal and in linkage disequilibrium [17]. In this study, we re-
examined our initial analysis using data from the expanded
scheme and much larger isolate collection by estimating index of
association (IA) values. An IA value not significantly greater than
zero after 1000 computer randomisations suggests linkage
equilibrium, while an IA value greater than zero is considered
clonal. When all isolates were analysed, we obtained an IA value of
0.483 (p,0.001), and with a representative of each ST an IA value
of 0.379 (p,0.001), confirming the clonal population structure.
We also took this opportunity to investigate the level of linkage
between alleles within the major P. acnes divisions (phylotypes I, II
and III). With all isolates from the type I clade (IA1, IA2, IB), an IA
value of 0.155 (p,0.001) was obtained. While still representing a
clonal structure overall, the drop in IA value indicated increased
linkage equilibrium within this population. Similarly, although the
numbers of type II and type III isolates analysed were smaller,
there was also a consistent drop in IA value to 0.065 (p,0.001) for
the type II population and 0.025 (p = 0.104) for type III. The latter
was not statistically significant indicating linkage equilibrium.
These results provide evidence to support the idea that the
different phylogroups of P. acnes may occupy distinct ecological
niches, where recombination is more frequent amongst individuals
of the same niche, but less frequent between isolates from different
niches [35]. Split graph analysis of allelic profiles from all 91 eSTs
provided further evidence for recombination events, primarily
within the major divisions (multiple interconnected pathways),
which were resolved into highly distinct clusters within the
network tree structure (Figure 2). Analysis of the population as a
whole revealed levels of recombination that were statistically
significant (phi test; p = 0.021).
Phylogenetic Analysis
As the tly and camp2 genes are under purifying selection, do not
display statistically significant levels of reticulate evolution, and
contain phylogenetically valuable information, they can also be
used in combination with the housekeeping genes for investigation
of phylogenetic relationships, as previously described with other
virulence-related genes [36,37]. To investigate this, we constructed
an ME concatenated gene sequence tree for all 91 eSTs (Figure 3).
The ME algorithim was chosen to enable direct comparison with
previously described trees in the literature [18,21]. Consistent with
our original MLST scheme, isolates were neatly resolved into
three major clades that corresponded to the main genetic divisions
I, II and III (bootstrap 99%) [17]. Furthermore, within the type I
clade, all isolates representing type IB STs formed a highly distinct
cluster (99% bootstrap) that was well separated in genetic distance
from type IA strains (Figure 3).
To assess the reliability of our eMLST method for sequence-
based clustering of strains within the large type IA clade, we
compared the topology of our tree with a recently published P.
acnes ME reference tree that was constructed using the concate-
nated sequences of 76 housekeeping genes (92,577 bp) extracted
from a total of 75 genomes (mostly from the HMP), the majority of
which represent type IA STs (84%) along with a small number of
type IB (5%) and type IIs (11%) [18]. As expected, the small
number of representative type IB and type II STs in this collection
formed highly distinct clades (100% bootstrap values) that
matched the topology of our eMLST tree (Figure 3). The
clustering of strains within the type IA division was also found to
be highly congruent between our eMLST tree and the published
reference tree [18]. In particular, type IA isolates clustered into
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two highly distinct groups ($75% bootstrap values) that corre-
sponded to the recently proposed type IA1 and type IA2 divisions
[19]. Within our eMLST tree, the majority of type IA1 isolates
(,95%) clustered into three groups that corresponded to the
clonal complexes CC1 (CC18, Aarhus), CC3 (CC3, Aarhus), CC4
(CC31, Aarhus), and this again matched the topology of the
reference tree (Figure 3) [18].
In contrast to all other HMP isolates, the published P. acnes
reference tree identified that HL097PA1, SK187, HL025PA1 and
HL086PA1 represent distinct lineages [18]. The unique nature of
HL097PA1 and SK187 isolates was also disclosed within our
eMLST tree (Figure 3). In particular, the isolate HL097PA1
formed a unique cluster (eST70; 3 isolates), along with the isolate
PV66 (eST85; 1 isolate), which was highly distinct from all other
type IA isolates (Figure 3). Identical clustering was observed on the
reference tree [18]. These eSTs were also highly distinct based on
the Neighbour-net splits tree of allelic profiles (Figure 2) and were
singletons upon eBURST analysis (Figure 1). Isolates within this
cluster correspond to the novel type I grouping highlighted earlier.
On an ME concatenated gene sequence tree constructed from
Aarhus MLST STs, the unique nature of HL097PA1 (Aarhus,
ST74) was also disclosed, but the isolate clustered within a distinct
type IA clade, along with STs from CC18 (ST29), CC28 (ST70)
and CC31 (ST31) (Figure S4). This distinct cluster, previously
described as I-1b [21], was not observed on the eMLST tree or the
P. acnes reference tree [18]. In keeping with the unique status of
eST70 and eST85 isolates, we found that they reacted with our
previously described type IA (QUBPa1) and type II (QUBPa2)-
specific MAbs [12,17]. These antibodies target cell surface
dermatan sulfate-binding adhesins (DsA1; DsA2) and a glycolip-
id-containing antigen on type IA and type II strains, respectively
[12,17]. Furthermore, these isolates contain unique recA and tly
alleles (Table S1). While all isolates identified as type IC to date are
resistant to tetracycline and erythromycin due to rRNA mutations
(Table 2), it is too early to ascertain if mutational resistance will be
a defining feature of further STs within this cluster. Based on their
unique phylogenetic and phenotypic properties, as well as
potential clinical importance, we now formally propose this group
as type IC.
With respect to SK187, it had a distinct ST (eST19) that
clustered separately from all other type IA isolates, and was also a
singleton upon eBURST analysis (Figure 1). The distinct nature of
this isolate was also previously reported by our seven gene MLST
scheme (ST39) [17]. In the Aarhus scheme, the unique nature of
SK187 was not detected as it shared the same ST (Aarhus, ST67)
with HL037PA1 and clustered within the Aarhus type IA2 clonal
complex CC28 (Figure S4) [18]. SK187 has previously been
shown to share a genomic region with the type IB strains
KPA171202 and HL030PA1, which encodes ABC transporters,
conjugal transfer systems and lanthionine biosynthesis [26]. It also
shares many gene alleles with type IA2 isolates including recA. In
Figure 2. Neighbour-net splits graph of allelic profiles from all 91 P. acnes eSTs. Parallelogram structures indicative of recombination are
clearly present within the major divisions I, II and III. Overall levels of recombination within the population were statistically significant (phi test;
p = 0.021).
doi:10.1371/journal.pone.0041480.g002
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this study we classified SK187 within the type IA1 group based on
its phylogenomic clustering [18].
The unique nature of HL025PA1 or HL086PA1 was not
disclosed by the eMLST scheme, which classified both isolates as
eST4 (CC4) (Figure 2). While the Aarhus MLST scheme did
resolve the isolates into unique STs (ST27; ST31) their aberrant
genetic nature was similarly not detected and both isolates
belonged to CC28 (equivalent to eMLST CC4) (Figure S4) [18].
Comparison of eMLST and Aarhus MLST Schemes
We compared our eight locus eMLST scheme with the nine
locus Aarhus scheme based on a range of criteria. Firstly, using
data currently available in the MLST databases, we calculated
that the mean number of alleles per locus based on the eMLST
scheme is 17.8 compared to 12.1 for the Aarhus method. This
provides the opportunity for the resolution of 161010 and 56109
genotypes, respectively. We then examined the two schemes for
the number of STs resolved and eBURST clustering based on
using a panel of 86 isolates, which included 70 from the HMP and
other whole genome sequencing projects, and 14 Danish isolates
described in the original Aarhus MLST publication [21]. During
our analyses we noted a significant number of inconsistencies
between our ST designations and those recently reported by
Kilian and coworkers using the Aarhus MLST scheme [18] [we
also noted other inconsistencies in ST designations within the
Aarhus database (http://pacnes.mlst.net/)]. These differences,
which are highlighted in Table S2, result in an overrepresentation
of unique Aarhus STs in their publication [18]. Overall, the
eMLST scheme discriminated a greater number of STs (33 versus
28), and CCs (7 versus 6) compared to the Aarhus method (Table
S2). The eMLST scheme also identified a greater number of
singletons compared to the Aarhus protocol (7 versus 2) (Table S2).
Both methods were essentially concordant with respect to the
clustering of the 86 isolates into CCs, although a small number of
exceptions were noted (Table S2). In addition to the aberrant
isolates described earlier, isolates HL030PA2 and HL063PA2
were identified as singletons based on eMLST, but clustered
within CC28 based on the Aarhus method [18]. Their distinct
nature from strains within CC28 is supported by the P. acnes
reference tree and also a distinct 16 S rRNA allele [18]. These
isolates were also correctly highlighted as distinct using our
previous seven gene MLST scheme [17,18]. With type II strains,
two clonal complexes (CC6; CC72) were identified by eMLST
compared to only one clonal complex (CC60) using the Aarhus
method.
Data presented in Table S2 also highlights the importance of no
longer using recA for the sole identification of type IB isolates as
previously described, although it still remains a highly robust locus
for identification of types I, II and III [6,12,32–34]. While the
method appears 100% sensitive for detection of type IB strains,
more in-depth MLST analyses have shown it lacks specificity due
to sharing of the type IB allele with type IA1 isolates from CC4 and
all type IA2 isolates (CC2), thus leading to potential misidentifi-
cation of certain type IA isolates as type IB. All isolates that we
previously described as type IB based on recA typing have been re-
examined by eMLST and their original classification does,
however, remain correct [12–16].
Investigation of ‘Pathogenic’ Versus ‘Commensal’ P.
acnes Strains
Under normal circumstances, P. acnes has an important role in
maintaining the ecosystem of healthy skin by occupying niches
that could otherwise be invaded by pathogenic microorganisms
[38]. Despite this positive effect on our health, it is also widely
recognised that if given the opportunity, P. acnes can cause a range
of different infections. What is much less certain is whether this is a
characteristic of all P. acnes strains, or whether specific pathogenic
lineages exist alongside truly benign commensal strains that are
only ever associated with maintaining health. To properly address
this issue, it is important that we analyse a large cohort of isolates,
and not just from acne, but from a wide range of P. acnes-associated
diseases, as well as healthy skin.
Previously, we found that the MLST genotype ST6 was
associated with various infections and conditions, particularly
inflammatory acne [17]. We re-visited the association of ST6 with
disease by looking at the relationship between STs further resolved
from ST6 by subtyping and various infections and conditions
(Figure S5). The most prevalent of the genotypes identified, eST1
(n = 50) was associated with moderate-to-severe acne (n = 25; 24%
acne-associated isolates) and was globally dispersed. The P. acnes
type strain NCTC737, isolated from an acne patient in London
over 90 years ago, was also eST1 based on our scheme (equivalent
to ST18 in the Aarhus scheme). The endocarditis isolate 889,
previously used to study the pro-inflammatory reaction of
sebocytes and keratinocytes, was also eST1 [16,39]. In our
collection, we also have isolates of eST1 recovered from dental
(n = 2) and ophthalmic infections (n = 7) and fatal head granulo-
mas (n = 2) providing further evidence that the pathogeneic profile
of this lineage is not just confined to acne (Table S1; Figure S5).
Furthermore, eST1 was also isolated from healthy skin (n = 13)
demonstrating that it may also be a normal component of the skin
microbiota.
The other prevalent MLST genotypes represented by eST3
(n = 26) and eST4 (n = 15) represented 17% and 8% of acne
isolates, respectively. These STs were also widely disseminated and
found in association with other conditions, including ophthalmic
and soft tissue infections as well as healthy skin (Table S1; Figure
S5). The remaining STs derived upon ST6 subtyping were isolated
from acne, soft tissue infections and skin (Table S1; Figure S5). As
expected, no clear differences were observed in the associations
between the three clonal complexes (CC1, CC3 and CC4) derived
from the previously described CC6 and acne or other clinical
conditions; this suggests that although these complexes may indeed
differ in genomic content this may not necessarily reflect
differences in disease potential [18].
While our previous study found no association between isolates
from the type IA2 division and acne [17], in this current study with
a larger isolate collection we did identify nine type IA2 STs
recovered from the skin of acne patients. This represents, however,
only 9% of all the acne-associated isolates and 28% of the total
number of type IA2 isolates identified. This rate of recovery from
Figure 3. Minimum evolution phylogenetic tree of concatenated gene sequences from all 91 P. acnes eSTs. The tree was constructed
using concatenated sequences (4253 bp) from each eST. The sequence input order was randomized, and bootstrapping resampling statistics were
performed using 500 data sets. Bootstrap values are shown on the arms of the tree. Horizontal bar represents genetic distance. Coloured vertical bars
on the right relate to eBURST groupings or clonal complexes. The colour scheme relating to each eBURST group is described, with singletons
highlighted in red. Culture collection strain NCTC737 (type IA1) is represented by eST1 (ST18, Arahus), KPA171202 by eST5 (ST36, Arahus), CCUG32901
by eST5 (ST36, Arahus) and ATCC11828 by eST27 (novel ST, Arahus).
doi:10.1371/journal.pone.0041480.g003
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acne patients is similar to that seen with type IB and type II isolates
(Table 3). A large proportion of type IA2 isolates were associated
with healthy skin (n = 14; 44% total) while the remainder were
isolated from ophthalmic infections (n = 8; 25% total) and one
isolate was associated with an intravenous catheter (n = 1; 3%
total) (Table S1; Figure S5). In contrast, within the type IA1
division we find that acne isolates account for approximately 50–
60% of all the isolates within the three major clonal complexes
Table 2. Summary of eMLST, monoclonal antibody typing and antibiotic susceptibility testing results for antibiotic-resistant P.
acnes strains.
rRNA mutation(s) MICb
Isolate Phylotype Region Source
Antibody
typinga Allelic profile eST CC 16 S 23 S TC EM CL Erm(X)
PRP-062 IA1 Italy Acne IA 1-1-1-9-1-1-1-1 49 CC1 2 + (2058) 32 $256 32 –
308.2 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + 2 8 0.032 0.025 –
322.2 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + 2 8 $256 1 –
401.5 IA1 Sweden Acne IA 1-1-1-3-1-1-1-2-2 3 CC3 + + (2057) $256 4 0.5 –
411.2 IA1 Sweden Acne IA 1-1-1-3-1-1-1-1 1 CC1 + + (2058) 8 $256 16 –
413 IA1 Sweden Acne IA 1-1-1-3-1-1-17-33 88 S + 2 8 0.032 0.032 –
416.1 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + + (2059) 8 $256 2 –
423.1 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + 2 8 0.032 0.5 –
423.3 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + 2 8 0.032 0.25 –
425.1 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 4 $256 16 –
429.1 IA1 Sweden Acne IA 1-1-1-3-1-1-2-2 3 CC3 + - 8 0.5 0.5 –
R11883 IA1 UK Blood IA 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 6 $256 32 –
R20767 IA1 UK Pus IA 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 6 $256 8 –
PRP-002 IA1 Australia Acne IA 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 8 $256 8 –
PRP-003 IA1 UK Acne IA 8-1-1-3-1-1-2-2 43 CC3 + 2 24 ,0.016 0.016 –
PRP-004 IA1 UK Acne IA 1-1-1-3-1-1-1-1 1 CC1 + 2 8 ,0.016 0.023 –
PRP-053 IA1 Australia Acne IA 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 3 $256 1.5 –
PRP-101 IA1 USA Acne IA 1-1-1-3-1-1-2-2 3 CC3 + + (2059) $256 $256 1.5 –
PRP-102 IB USA Acne Atypical 1-1-1-4-1-4-8-21 42 CC5 + + (2059) 12 $256 0.5 –
PV66 IC UK Acne Atypical 9-1-5-8-6-8-14-6 85 S + + (2058) $256 $256 24 –
PRP-038 IC UK Acne Atypical 9-1-4-8-6-8-14-14 70 S + + (2059) 32 $256 0.38 –
PRP-039 IC UK Acne Atypical 9-1-4-8-6-8-14-14 70 S + + (2059) $256 $256 0.38 –
PRP-047 II Greece Acne II 1-4-2-4-2-3-10-10 61 CC6 2 + (2059) 0.25 $256 2 –
PRP-078 IA1 Japan Acne IA 1-1-1-3-7-1-22-2 86 S 2 + (2059) 0.125 $256 24 –
434 IA1 Sweden Acne n/d 5-1-1-3-1-1-1-1 20 CC1 2 2 $256 $256 nd –
226 IA1 Sweden Acne n/d 1-1-1-3-1-1-2-3 31 CC3 2 2 8 $256 nd –
HL097PA1 IC USA Acne n/d 9-1-4-8-6-8-14-14 70 S + + (2058) nd nd nd –
HL045PA1 IA1 USA Acne n/d 1-10-1-3-1-1-2-2 17 CC3 + + (2058) 16 $256 $256 –
HL007PA1 IA1 USA Skin n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 24 $256 $256 –
HL038PA1 IA1 USA Acne n/d 1-1-1-3-1-1-2-4 10 CC3 + + (2059) 4 $256 0.875 –
HL099PA1 IA1 USA Acne n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 6 $256 $256 –
HL053PA1 IA1 USA Acne n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 6 $256 $256 –
HL056PA1 IA1 USA Skin n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 16 $256 $256 –
HL074PA1 IA1 USA Skin n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 24 $256 $256 –
HL096PA2 IA1 USA Skin n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 6 $256 $256 –
HL043PA1 IA1 USA Acne n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 8 $256 $256 –
HL043PA2 IA1 USA Acne n/d 1-1-1-3-1-1-2-2 3 CC3 + + (2058) 3 $256 $256 –
HL072PA1 IA1 USA Acne n/d 1-1-1-3-1-1-1-1 1 CC1 + + (2058) 12 $256 $256 –
HL072PA2 IA1 USA Acne n/d 1-1-1-3-1-1-1-1 1 CC1 + + (2058) 6 $256 $256 –
HL005PA1 IA1 USA Skin n/d 1-1-1-3-1-1-5-2 11 CC3 + + (2058) 8 $256 $256 –
aAntibody typing with type IA and type II monoclonal antibodies QUBPa1 and QUBPa2, respectively [12].
bTetracycline resistance MIC$1.0 mg/L; erythromycin resistance MIC$0.5 mg/L; clindamycin resistance MIC $0.25 mg/L.
doi:10.1371/journal.pone.0041480.t002
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CC1, CC3 and CC4 (p,0.01). The re-appraisal of IB2 isolates as
type IA2 now means that nearly all cases of acne and ophthalmic
infections appear associated with type IA organisms. On this basis,
and using the much greater number of clinical isolates now in our
collection, we have updated our previously published table [17]
highlighting the breakdown of the P. acnes phylotypes isolated from
acne and ophthalmic infections, and also included data relating to
healthy skin (Table 3). It is currently unclear why type IA2 isolates
appear to be less frequently recovered from acne patients
compared with type IA1 strains. In particular, all type IA1 and
IA2, but not type IB, II or III isolates, express the dermatan-sulfate
binding adhesins DsA1 and DsA2, which have the capacity for
phase/antigenic variation [17]. Dermatan sulfate is the predom-
inant glycosaminoglycan in skin and a biological response modifier
involved in various processes. While previous studies have
suggested that their expression by type IA strains may provide
an explanation, at least in part, for their association with acne and
the recurrent nature of the disease [17,26], the infrequent recovery
of IA2 strains from acne patients despite their capacity to produce
these proteins clearly confirms the importance of other factors. In
the context of acne, the latter are likely to include lipase,
neuraminidase, iron acquisition proteins and inflammation-induc-
ing molecules [15,16,21,25,26,39]. Furthermore, the re-appraisal
of type IB2 isolates as type IA2 now confirms that our previously
described monoclonal antibody QUBPa1 is type IA-specific, and
does not show any reaction with isolates from the type IB division
in line with their distinct nature [12,17].
While type IB and type II isolates appear associated with acne
and ophthalmic infections in very small numbers relative to type
IA1, a combined total of 18 out of 23 medical device related
infections were associated with isolates from these two divisions
(Table S1; Figure S5). Other type IB and II isolates were
associated with dental, soft tissue infections and were also isolated
from normal skin. Most type III strains were primarily isolated
from spinal disc material and normal skin. Collectively, these data
are consistent with previous observations suggesting that type IB,
II and III strains are more frequently associated with blood, soft
tissue and medical implant-related infections [6,12,17,21,34]. It is
unclear, however, if this association is clinically relevant in many
cases, and for medical implants, if it indicates a possible tropism
for such surfaces. The clinical associations of all the isolates
analysed in this study are detailed in Table S1.
In total, 21 STs were identified only on healthy skin and not
associated with infection or a clinical sample (Table S1, Figure 1
and S5). Of particular note was CC72 (type II) and CC77 (type
III), in which 50% of the isolates appeared health-associated. A
proportionately smaller number of STs within CC1, CC3 and
CC4 were also associated with healthy skin, but it remains to be
determined if these are truly non-pathogenic, while other STs
within these complexes have heightened capacity to cause disease.
While the exact clinical significance of the isolates from patient’s
samples may be unclear in some cases, the identification of
apparent healthy skin-associated STs is consistent with a view that
pathogenic versus commensal strains of P. acnes may indeed exist.
Population Genetic Analysis of Antibiotic Resistant P.
acnes Isolates
Acne vulgaris is a disease of the pilosebaceous follicle and has a
multifactorial aetiology. The association of P. acnes with acne
vulgaris has a long history, although the exact role of the
bacterium in the pathophysiology of the disease still remains
controversial. The successful treatment of acne patients with both
oral and topical antibiotics over the last 40 years has provided
evidence in support of P. acnes involvement in acne, although the
direct or indirect anti-inflammatory activity of these agents may
also contribute to their effectiveness [2,38]. As individual
treatments can last for months to even years, it is no surprise
that strains of cutaneous propionibacteria resistant to the main
antibiotics used to treat acne (tetracyclines, erythromycin,
clindamycin) have emerged. Amongst the different approaches
utilised by P. acnes to confer resistance to anti-acne agents, specific
point mutations in the rRNA operon represent a major
mechanism [40,41]. P. acnes is an ideal candidate for such a
strategy as it contains only a small number of copies of the rRNA
operon with no evidence of heterogeneity. As a consequence, any
point mutations are not compromised by wild-type rRNA and
prolonged antibiotic usage positively selects for such mutants.
Resistance to tetracyclines is mediated by a single G-to-C base
transversion (equivalent base 1058 in Escherichia coli) (1058 G.C)
in the 16 S rRNA of the small ribosomal subunit [41]. Resistance
to erythromycin and clindamycin most commonly occurs via one
of three point mutations in genes that encode domain V of
23 S rRNA (peptidyltransferase loop) [40], but in a minority of
isolates resistance is associated with the presence of erm(X) [42]. A
2058 A.G mutation confers high erythromycin resistance and
variable resistance to other macrolides and clindamycin, while a
2057 G.A mutation is associated with low erythromycin resis-
tance. A 2059 A.G mutation confers high resistance to all
macrolides and elevated, but variable, resistance to clindamycin.
To date, no detailed population genetic study based on MLST has
been carried out on isolates containing such rRNA mutations, and
how they relate to previously described phylogroups. Within our
isolate collection, and including the HMP strains, we identified a
total of 38 isolates that have one or more rRNA mutations that
would confer antibiotic resistance to anti-acne antibiotics (Table 2).
A further two resistant isolates were identified without any rRNA
mutations indicating alternate mechanisms for resistance (Table 2).
Both isolates were from Sweden and negative for erm(X).
Overall, 85% of the resistant isolates belonged to the type IA1
group, which was consistent with our data demonstrating that this
phylogenetic cluster was highly associated with acne. Only one
type IB (PRP-102) and one type II (PRP-047) isolate were
identified, recovered from acne patients in the USA and Greece,
respectively. PRP-102 demonstrated multiple resistance to all
antibiotics tested, while PRP-047 was resistant to erythromycin
and clindamycin. No type IA2 or type III isolates from our
collection were found to carry these mutations, again consistent
with their low rate of recovery from acne lesions. All type IC
isolates tested to date were resistant to erythromycin and
Table 3. Breakdown of phylotypes for normal skin, acne and
ophthalmic infections.
Ophthalmic infections
Phylotype Skin Acne Keratitis Endophthalmitis Eyea
IA1 30 (39%) 77 (74%) 11 (58%) 4 (40%) 1 (50%)
IA2 14 (18%) 9 (9%) 4 (21%) 4 (40%) 0 (0%)
IB 7 (9%) 6 (6%) 2 (10%) 1 (10%) 1 (50%)
IC 0 (0%) 4 (4%) 0 (0%) 0 (0%) 0 (0%)
II 12 (16%) 8 (8%) 1 (5%) 1 (10%) 0 (0%)
III 14 (18%) 0 (0%) 1 (5%) 0 (0%) 0 (0%)
Total 77 (100%) 104 (100%) 19 (100%) 10 (100%) 2 (100%)
aType of eye infection not available for isolate.
doi:10.1371/journal.pone.0041480.t003
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tetracycline as a result of rRNA mutations, with some variability in
the nature of their 23 S mutation; two isolates have 2058 A.G
and two isolates 2059 A.G mutations in 23 S rRNA (Table 2). At
a deeper level of analysis, ,65% of the resistant isolates belonged
to type IA1 CC3 and, of these, 84% were eST3 (ST3, Aarhus).
Two singletons, 413 (eST88) and PRP-078 (eST86) were also
double locus variants of eST3. An intriguing result from this
analysis is the relatively low abundance of rRNA mutations in
isolates from CC1, which is also strongly associated with
moderate-to-severe acne, at least based on culture detection
methods. Only six isolates (15%) were identified from this
complex, four eST1 (ST18, Aarhus) along with eST49 (PRP-
062) and eST20 (434). It should be noted, however, that in acne
patients, P. acnes within the hair follicle forms large aggregates that
may reflect biofilm production [43], which would intrinsically
increase antibiotic resistance [44]. It is, however, difficult to draw
any definitive conclusions on the clinical significance of these data
until a wider prospective study is conducted and a greater number
of isolates are analysed. Eight isolates were resistant to tetracycline
via the 16 S rRNA 1058 G.C mutation (nearly all Swedish) but
were susceptible to macrolides and clindamycin, whereas 26
isolates carried the 1058 G.C mutation in combination with
23 S rRNA 2058 A.G or 2059 A.G conferring resistance to
tetracyclines, macrolides and sometimes lincosamides. Notably,
isolates from the USA carrying a 2058 A.G mutation were more
likely to be highly resistant (MIC $256 mg/L) to clindamycin
than isolates from elsewhere (MIC 1.5–32 mg/L); this suggests the
presence of one or more additional uncharacterised mechanisms
conferring resistance to clindamycin in these isolates. Erm(X) was
not detected, but we cannot rule out the presence of a different erm
gene. We recognise that our collection does not fully reflect the
relative prevalence of different resistant phenotypes and genotypes
as described in the literature [45,46,47,48] and that tetracycline
resistant and multiply resistant strains are over-represented.
The presence of rRNA mutations in distinct lineages represent-
ing types IA1, IB, IC and II clearly demonstrates independent
antibiotic selection events. This is further supported by the
observation of identical rRNA mutations conferring resistance to
erythromycin and tetracycline in the closely related cutaneous
species Propionibacterium granulosum and Propionibacterium. avidum
[40,41]. The identification, however, of geographically widespread
isolates of eST3, all with the same rRNA mutations (16 S rRNA
1058 G.C; 23 S rRNA 2058 A.G) does highlight the possibility
of dominant resistant clones circulating across continents. Further
evidence to support the view that these clones may be widely
transmitted through populations comes from the isolation of
resistant eST3 from healthy adult skin (Table 2). None of the
healthy adults from which these strains were isolated were being
treated with antibiotics. Variations in MIC values within this
particular clonal lineage may also indicate complemetary antibi-
otic selection events leading to increased resistance in some cases.
An additional number of geographically distinct strains with
unique STs were also identified with rRNA mutations. These
include the type IA1 strain PRP-062 from Italy (CC1, eST49)
which had a 23 S rRNA 2058 A.G mutation only, but also
demonstrated high tetracycline resistance, and PRP-047 (type II;
CC6, ST61) and PRP-078 (type IA1; singleton, ST86) from
Greece and Japan, respectively which had 23 S rRNA 2059 A.G
mutations. One Swedish isolate 401.5 (type IA1; CC3, eST3) from
a patient in Stockholm had 16 S rRNA 1058 G.C and
23 S rRNA 2057 G.A mutations, the latter being uncommon.
Consistent with these sequences, the isolate displayed high
tetracycline resistance and lower levels of erythromycin resistance
(Table 2). Finally, resistant isolates from Sweden, 434 (type IA1;
ST20, CC1) and 226 (type IA1; ST31, CC3) with wild type rRNA
sequences were identified. These strains had high level resistance
that was clearly mediated via other mechanisms, although these
were not identified as part of this study. Both strains were,
however, negative for the presence of the erm(X) resistance gene.
Conclusions
The expanded eight gene MLST scheme described offers high
resolution typing of P. acnes. When compared against a large panel
of test isolates, the method produced an overall level of
discrimination that was higher than the nine-gene method
developed at the University of Bath, UK and adopted by the
Aarhus group [21]. Furthermore, the clustering of isolates based
on analysis of both concatenated sequence data and allelic profiles
was highly concordant with phylogenies based on phylogenomic
analysis, and also correlated with gene contents and putative
pathogenic potential.
Application of the high resolution scheme to a large collection of
isolates from disparate geographically widespread clinical sources,
as well as healthy skin, revealed particular lineages that appeared
to have a heightened capacity to cause infection (particularly,
eST1, eST3) when compared to other strains that were only ever
isolated from healthy skin, particularly certain STs from CC72
(type II) and CC77 (type III). Whether the latter strains truly
represent ‘commensal’ lineages still remains to be firmly estab-
lished, but the ability to stratify P. acnes into isolates that are
opportunistic pathogens versus those associated with health would
have a number of important ramifications. In particular, from a
clinical point of view it opens the possibility of developing novel
antimicrobial strategies for acne and other P. acnes-related diseases
if specific mechanisms leading to enhanced virulence potential can
be pinpointed. From a diagnostic perspective, the ability to identify
pathogenic versus benign strains may aid diagnostic bacteriologists
in their attempts to determine whether P. acnes recovered from a
patient’s sample is clinically meaningful, or simply reflects
contamination with commensal microbiota. Furthermore, in the
future, the development of molecular tests for high throughput
differentiation of P. acnes into the different phylotype groupings
(IA1, IA2, IB, IC and III) would be very valuable, and enable
stratification of isolates for downstream MLST analysis.
Due to its relatively low number of rRNA operons, mutations in
rRNA have been a significant mechanism utilised by P. acnes to
evolve resistance to anti-acne antibiotics. One key finding from
our analysis of such isolates is the apparent dominance of these
types of mutation in CC3, particularly eST3 the founder of this
complex. In contrast, isolates from CC1 were represented in low
numbers despite the high association of this complex with acne,
and its founding genotype eST1 being widely disseminated and the
most prevalent ST from moderate-to-severe cases of the disease.
Our data also provide tentative evidence that multiple antibiotic
resistant eST3 is circulating across continents. A prospective
MLST study based on a greater cohort of such isolates will
hopefully confirm and expand these results.
Our original work on the phylogenetic structure of P. acnes
identified the main phylotypes or phylogroups termed IA, IB, II
and III [12–14]. This nomenclature, which has now been refined
based on MLST analyses and whole genome sequencing data to
include IA1, IA2, IB, IC, II and III [12–14,17,19], is supported at
the clinical and phenotypic level and has been widely used in the
literature. It remains a robust and highly valuable system for
classification of P. acnes strains. We recommended that in future
communications STs and CCs are described in the context of
these divisions as this will provide continuity with a large number
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of previously published studies and avoid unnecessary confusion
that will benefit no one.
Materials and Methods
Bacterial Strains
A total of 285 P. acnes isolates were examined in this study,
including the type strain NCTC737 (type IA1; facial skin acne
isolate) which was obtained from the National Collection of Type
Cultures (NCTC), and reference strains ATCC11828 (type II;
human abscess) from the America Type Culture Collection
(ATCC), CCUG32901 (type IB; human blood) from the Culture
Collection, University of Go¨teborg (CCUG) and KPA171202
(type IB; DSM 16379; contaminated anaerobic culture) which was
from the German Collection of Microorganisms and Cell
Cultures. Table S1 summarizes all the isolates analyzed in this
study (n = 285) and includes those currently comprising the HMP
and other published genome sequencing projects [28,29,30]. A
total of 104 isolates were from patients with acne, 31 were from
ophthalmic-related infections (bacterial keratitis and endophthal-
mitis), 27 were associated with soft-tissue infections, surgical skin
wounds and blood, six with dental infections, 13 with spinal disc
material, 14 from sonicate prepared from failed prosthetic hip
joints and 10 from intravascular catheters. A total of 77 isolates
were from healthy skin. The remaining isolates were from a bone
infection, contaminated culture and cadaveric skin.
Bacterial Culture
All bacterial strains were maintained at 280uC in Brain Heart
Infusion (BHI) broth, containing 12% (v/v) glycerol, pending
analysis. Organisms were cultured on anaerobic blood agar at
37uC in an anaerobic cabinet (Mark 3; Don Whitley Scientific)
under an atmosphere of 10% H2, 10% CO2, 80% N2 prior to
analysis.
MLST Analysis
Partial sequences of the housekeeping gene loci aroE (424 bp),
atpD (453 bp), gmk (400 bp), guaA (493 bp), lepA (452 bp), recA
(463 bp) and sodA (450 bp) were amplified using primer pairs and
amplification conditions previously described [17]. Complete gene
sequences from the ‘putative virulence’ determinants tly (777 bp)
and camp2 (804 bp) were amplified using the methods described in
McDowell et al. [12] and Valanne et al. [14], respectively. PCR
products were purified on MiniElute UF plates (Qiagen) and
sequenced as detailed previously [17]. Novel alleles for each locus
were assigned a new allele number and distinct allelic profiles
assigned a new ST number. All allele sequences are available at
(http://pubmlst.org/pacnes).
Identification of Antibiotic Resistance Genes
Mutations in both 16 S and 23 S rRNA loci conferring
antibiotic resistance were identified by PCR using published
primers and amplification conditions [46], followed by nucleotide
sequencing as previously described [17]. Detection of erm genes
(erythromycin ribosome methylase) was investigated using a PCR
assay that targets a 167 bp fragment of the gene [46].
Data Analysis
For ‘putative virulence’ genes, G+C content, the number of
polymorphic sites, the average number of synonymous and non-
synonymous sites, the average synonymous/non-synonymous site
ratio (dNdS), the nucleotide diversity per site (p) and the average
number of nucleotide differences per site (h) were determined
using DnaSp version 5 [49]. Phylogenetic relationships were
investigated with the Minimum Evolution (ME) algorithm using
MEGA v 4.0. Split decomposition trees were generated using
SplitsTree version 4.1 [50]. Evidence for recombination break-
points was assessed using the GARD method [51]. Individual
codons were also analyzed for positive selection using the SLAC,
MEME and PARRIS methods with the REV and HKY85 models
of nucleotide substitution [51,52,53]. Index of association values
(IA) were determined following the method of Haubold & Hudson
[54] with LIAN v3.5 software. Clonal groups were identified using
the eBURST v3 clustering algorithm which will also identify the
most likely (i.e., parsimonious) ancestral ST within each clonal
complex (http://www.mlst.net) [55].
Antibody Typing
Monoclonal antibody (MAb) typing by immunofluorescence
microscopy (IFM) was carried out as described previously [12].
Isolates were examined for their reactivity with mouse monoclonal
antibodies QUBPa1 and QUBPa2, which target strains within
types IA1 and II, respectively [12,13,17].
Susceptibility Testing
Susceptibility to the antibiotics tetracycline, erythromycin and
clindamycin was determined using E-test strips (AB BIODISK,
Sweden) according to the manufacturer’s instructions. The MIC
values were determined after 48 hours anaerobic incubation at
37uC.
Supporting Information
Figure S1 Minimum evolution phylogenetic tree of
amino acid sequences from the CAMP factor homo-
logues of the P. acnes type strain NCTC737 (type IA1;
eST1). Sequences were analysed using the Dayhoff Point
Accepted Mutation (PAM) matrix algorithm and bootstrapping
resampling statistics were performed using 500 data sets. The
CAMP factor sequences from Streptococcus pyogenes (accession no.
NP_802366.1), Streptococcus uberis (accession no. AAA78910.1) and
Streptococcus agalactiae (GenBank accession no. NP_736433.1), were
used as outgroups.
(TIFF)
Figure S2 Minimum evolution phylogenetic trees for tly
(A) and camp2 (B) genes. Both trees were essentially concordant
with that previously obtained using housekeeping loci, with the
major divisions (I, II and III) forming distinct and highly
significant clades (100% bootstrap values). Some evidence for
limited recombination within the type I division was identified; in
particular tly allele 8 which was present in all type IB and 97% IA2
isolates was also shared amongst 18% type IA1 isolates, while
camp2 alleles 1 and 6 were shared between different isolates of type
IA1 and IB.
(TIFF)
Figure S3 Split decomposition analysis of tly (A) and
camp2 (B) allele sequences. Some evidence of recombination
events was apparent due to the presence of multiple pathways that
formed parallelogram structures, but this was very limited. There
was no statistically significant evidence of recombination using the
phi test (tly, p = 0.91; camp2, p = 0.78).
(TIFF)
Figure S4 Minimum evolution phylogenetic tree of
concatenated gene sequences from 77 P. acnes STs
currently comprising the Aarhus MLST database. Se-
quence input order was randomized, and bootstrapping resam-
pling statistics were performed using 500 data sets. Bootstrap
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values are shown on the arms of the tree. Horizontal bar
represents genetic distance. Coloured vertical bars on the right
relate to eBURST groupings or clonal complexes. The colour
scheme relating to each eBURST group is described, with
singletons highlighted in red.
(TIFF)
Figure S5 Qualitative analysis grids highlighting the
relationship between P. acnes eSTs, different clinical
sources and healthy skin (highlighted in colours). (A)
eSTs derived from ST6 by subtyping. Soft tissue relates to fatal
head granulomas, endocarditis, blood cultures, lagophtalmus, a
cancerous prostate and abscess (B) all 91 eSTs derived for 285
isolates. Soft tissue relates to fatal head granulomas, endocarditis,
blood cultures, lagophtalmus, lymph nodes, cancerous prostates,
abcesses, a pleuropulmonary infection and kidney infection.
(DOC)
Table S1 eMLST results for all 285 P. acnes isolates
analysed in this study. A total of 91 eSTs were generated
based on the analysis of eight gene loci.
(DOC)
Table S2 Comparison of P. acnes MLST schemes. The
eMLST (eight loci) and Aarhus MLST (nine loci) schemes were
compared against a panel of 86 isolates representing different
phylogenetic groups of P. acnes (IA1, IA2, IB, IC, II). STs were
clustered within the same CC if they shared 7/8 alleles (eMLST)
or 8/9 alleles (Aarhus) with at least one other ST.
(DOC)
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